This case series highlights risk factors for infection by a non-tuberculous mycobacterium. Ananya Gupta @drabhi.bsky.social et al. link GATA2 mutation in the context of immune dysfunction to enhanced susceptibility to M. heamophilum infection in humans: buff.ly/pPIhSlx

Happy to share this interesting study which is now in press. We found specific Non-tuberculous mycobacterial susceptibility linked to GATA2 mutation in immunocompromised individuals @uchicagobsd.bsky.social @jci-insight.bsky.social insight.jci.org/articles/vie...

Newest paper from the lab out today (doi.org/10.1084/jem....)! Here, we describe PathMHC, a novel MS-based approach to identify rare pathogen-derived peptides on MHC-I and MHC-II. We apply this to a range of pathogens Mtb, SARS-CoV-2, and Listeria.

In the midst of everything take a break , protect your sanity and refuel to keep at it . #easter #timeoff #vitaminsea

Happy to be part of this cool paper ! BCG trial for prevention of COVID-19 in healthcare workers, interrupted with speedy arrival of the COVID vaccines. The vaccinated cohort 12-months later show improved COVID-19 immunity, key player DNA methylation! #BCG #DNAmethylation @globaltb.bsky.social

Happy 2025! Ready to get back to the science after a reset trip to beautiful #sanfrancisco #yosemite

A good day spent in listening to talks from four neighboring labs which are incidentally on the same floor . From #proteinengineering , #phageengineering , hightroughput #microfluidics and traditional conditional knockout #micemodels . #uchicago . Science is in good hands !

“Money reigns as perhaps the biggest obstacle” 🧪🩺

I made a Starter Pack for the Myco & TB community. Hope to find more good friends here on Bluesky to keep in touch about mycobacterial infections. Please join and repost! go.bsky.app/3nwpcVV